AUPH — Aurinia Pharmaceuticals Share News
0.000.00%
Last trade - 00:00- $2.23bn
- $1.84bn
- $283.06m
U.S. STOCKS ON THE MOVE-Eve Holding, Magnite, EHang Holdings
U.S. STOCKS ON THE MOVE-Lamb Weston, Robinhood, Eve Holding
U.S. STOCKS ON THE MOVE-Tech stocks, US big banks, Chime
Aurinia climbs as autoimmune drug shows antibody reduction in trial data
Brief: Aurinia Announces Positive Results From Phase 1 Study Of Aritinercept
Aurinia Pharmaceuticals Inc reports results for the quarter ended March 31 - Earnings Summary
Aurinia Pharmaceuticals Inc expected to post earnings of 10 cents a share - Earnings Preview
Brief: ISS Recommends That Aurinia Shareholders Vote "For" All Proposals At 2025 Annual General Meeting
Aurinia Pharmaceuticals Inc expected to post earnings of 10 cents a share - Earnings Preview
Brief: Concerned Shareholders Of Aurinia Pharmaceuticals Announce Their Intention To Withhold Support For CEO Peter Greenleaf At 2025 Annual Meeting
Aurinia Pharmaceuticals Inc reports results for the quarter ended December 31 - Earnings Summary
Aurinia Pharmaceuticals Inc expected to post a loss of 2 cents a share - Earnings Preview
Aurinia Pharmaceuticals Inc expected to post a loss of 2 cents a share - Earnings Preview
U.S. STOCKS ON THE MOVE-BorgWarner, Digital Realty, Take-Two
U.S. STOCKS ON THE MOVE-Ralph Lauren, CoreCivic, WK Kellogg
Aurinia Pharmaceuticals Inc reports results for the quarter ended in January 1 - Earnings Summary
U.S. STOCKS ON THE MOVE-Guardant Health, AppLovin, Sarepta
Aurinia Pharmaceuticals rises on job cuts, restructuring
Brief: Aurinia Pharma Reports Q3 And Nine-Months 2024 Results, Announces Restructuring To Focus On Lupkynis And AUR200